GNRH1 and breast carcinoma: Here, we aim to enhance the breast cancer cell selectivity of a pore-forming or C-terminal BinB domain (BinBC) by fusing it with luteinizing hormone-releasing hormone (LHRH) peptide, a targeting molecule for the LHRH receptor on the surface of breast cancer cells.